The common view that macrophage or dendritic cells (DCs) play prominent roles in propagating human immunodeficiency virus type 1 (HIV-1) in newly infected persons is largely based on in vitro characterization of virus isolates obtained during the acute and early stages of infection [1] [2] [3] [4] [5] [6] . These isolates, now designated R5 strains [7] because they use the chemokine coreceptor CCR5 for cell entry, are frequently termed nonsyncytium-inducing (NSI), since they do not form syncytia in MT-2 cells [8, 9] , and M tropic, because they are readily propagated in cultures of macrophages but not primary T cell lines [10] . The latter is a misnomer in the sense that R5 strains are, in reality, dual tropic, since they also can be propagated in primary cultures of activated CD4 T cells. In the symptomatic late stage of infection, virus isolates from ∼50% of infected persons use the chemokine coreceptor CXCR4 for entry, fuse MT-2 cells, and replicate in primary T cell lines. Because of these properties, they are described in the literature as syncytium-inducing (SI) T tropic virions or R4 strains [11, 12] . These observations have led
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In the nonhuman primate model of HIV-1 infection, detection of simian immunodeficiency virus (SIV) RNA or DNA in macrophages or unidentified cells, respectively, which, by their morphology, could have been DCs [16] [17] [18] [19] , has been interpreted as evidence in support of this model. However, in more recent studies, in which the type of viral RNA (vRNA)-positive cells was unambiguously established, most cells were CD4 T cells [16, 20, 21] , both in the animal model and in a small cohort of HIV-1-infected persons in the early stages of infection [20] . These findings suggested that the T cell might be the major source of virus, even in the early stages of HIV-1 infection, and that productive infection might be responsible for the decreased peripheral blood CD4 T cell counts in early infection. Thus, we analyzed the host range of productive infection in lymphoid tissue (LT), where most CD4 cells reside, in early HIV-1 infection. Here we describe the relationship between the frequency of productively infected cells and plasma vRNA levels, and the impact of productive infection on CD4 T cell depletion, when most CD4 cells reside in LT.
Patients and Methods

Demographic Characteristics of the Cohort
Patients were recruited from ongoing investigations of primary and early HIV-1 infection at 4 sites: University of Minnesota 
(UMN;
), University of Colorado Health Sciences Center n p 2 (UCHSC; ), University of Washington (UW; ), and n p 2 n p 8 University of California, San Diego (UCSD;
). Of the 21 n p 9 patients reported here, 15 experienced symptoms of an acute retroviral syndrome (median duration, 7 days; range, 4-45 days); thus, the date of seroconversion was based on the first day of symptom onset. The remaining 6 patients did not report any symptoms, and the date of seroconversion was assigned as the midpoint between the last negative and the first positive HIV antibody test.
At entry, baseline laboratory samples were obtained, and patients completed standardized interviews for the collection of clinical and epidemiologic information. Patients who agreed to have a lymph node biopsy performed had tissue removed by standard surgical techniques. Two biopsies were axillary, and 19 were inguinal. Specimens obtained from subjects in the first year of infection were appropriately preserved for in situ hybridization (ISH) and were sent to the UMN for analysis. All patients were antiretroviral therapy naive at the time of the biopsy. HIV-1 antibody testing was done by using EIA and Western blot techniques, according to the manufacturers' directions. T cell subset analysis was performed by flow cytometry. At the UW, HIV-1 RNA in plasma was determined by first generation bDNA assay (Chiron), which has a lower limit of HIV-1 detection of 10,000 copies/ mL of plasma [22] . Plasma samples that were !12,000 copies/mL were retested with the newer generation Chiron assay, with a lower limit of detection of 50 copies/mL. At UCSD, UCHSC, and UMN, HIV-1 RNA in plasma was determined by the Amplicor method (Roche), which has a lower limit of detection of HIV-1 RNA of 400 copies/mL of plasma [23, 24] 
ISH and Immunohistochemistry (IHC)
Identification of productively infected cell type. ISH was combined with IHC, to determine the cell type in which HIV-1 replicates in vivo. In brief, 8-mm sections of lymph node were pretreated and were hybridized to a set of 35 S-labeled riboprobes complementary to ∼90% of the full-length viral genome RNA. The sections were washed and blocked. The sections then were incubated sequentially with antibody to CD3 or CD68, to mark T cells or macrophages, respectively, and then with a secondary biotinylated antibody of the appropriate species and with an avidin-biotin complex. The cells that had bound antibody were stained by reacting with H 2 O 2 and 3,3 -diaminobenzidine (DAB) [20, 25] . The sections then were coated with nuclear track emulsion and were exposed, developed, and counterstained with hematoxylin. Cells that were positive for HIV RNA by silver grains and stained brown with DAB anti-CD3 antibody were scored as T cells. Cells that were colabeled DAB brown, using anti-CD68, and RNA positive were classified as macrophages (figure 1). T cells were classified further as CD4 cells with a monoclonal antibody that can react with paraffin-embedded fixed tissues. Because of the differences in fixation conditions at the participating centers, the combined use of ISH with satisfactory staining of CD4 T cells was possible in only 5 cases. However, in all 5 cases, the majority of RNA-positive T cells were CD4 cells, and the percentage of productively infected cells that were stained with anti-CD3 was the same as the number when stained with anti-CD4 (data not shown). Therefore, we used consistent staining with anti-CD3, to determine the percentage of HIV-1 RNA-positive T cells and the proportion of RNA-positive CD3 cells. In the reciprocal analysis of sections that were reacted with anti-CD68, we determined the proportions of HIV-1 RNA-positive macrophages and HIV-1 RNA-positive CD68 cells.
Viral production and replication in LT.
We defined productively infected cells as cells with 20 copies per cell of HIV-1 RNA, as described elsewhere [25] . We estimated potential production of virus by these cells in LT from their frequency. We took as a measure of viral replication the average number of copies of vRNA per cell, estimated by using ISH and quantitative image analysis (QIA), as follows: probe bound to vRNA in the cell generated a well-localized hybridization signal of silver grains overlying the cells ( figure 1 ). The number of silver grains per cell is proportional to the number of vRNA copies in the infected cell; therefore, the vRNA copy number could be estimated from the silver grain count, exposure time, 35 S efficiency, and the specific activity of the probe. This method of estimating copy number has been validated and is reproducible ‫%51ע‬ [25] . Video images of autoradiographs illuminated with epipolarized light were captured, and silver grains were enumerated automatically, using the Metamorph software program (version 4.1; Image1). The frequency of productively infected cells (no. of infected cells per gram of tissue) was calculated by counting the number of productively infected cells in node sections. We estimated weights from areas of sections by multiplying the thickness of the section by the density of fixed LT. The frequency was expressed as log 10 per gram of LT.
QIA of CD4 T cell populations in LT. Although ISH could be combined with IHC staining of CD4 T cells in only 5 cases, in 10 patients it was possible with antigen retrieval methods to use IHC alone to identify CD4 T cells and then to quantitate them per microgram of LT. Antigen retrieval was done on 8-mm-thick tissue sections by microwaving in 1 mM EDTA (pH 8.0). Sections then were treated with methanol, H 2 O 2 , and PBS containing 4% nonfat milk, to block nonspecific reactions, and then were incubated with anti-human CD4 monoclonal antibody (Novacastra). After a wash in PBS, the sections were reacted with biotinylated anti-mouse IgG and avidin-biotin complex, followed by staining with H 2 O 2 and DAB. Video images of the stained sections were captured and analyzed by using Metamorph threshold tools and filters, to distinguish stained cells from background and artifacts or stained cell processes. The measured area (in pixels) was converted to cell count from a predetermined standard area of a CD4 cell (determined as described in the preceding section). Total body CD4 cell count in LT was determined by multiplying all T cells per gram of LT by 700 g (approximate amount of LT in a 70-kg adult).
Results
Cohort description. We obtained LT from 20 men and 1 woman at a median of 133 days (range, 2-280 days) after the onset of symptoms that are associated with primary HIV infection. Four of the patients had biopsies performed within 15 days of the onset of symptoms or ∼3-4 weeks after the onset of infection, on the basis of a median incubation period of 12-14 days from exposure to the onset of symptoms [26] (table  1) . The remaining 17 biopsies performed spanned 45-90 days (3 biopsies), 91-180 days (7 biopsies), and 180-280 days (7 biopsies) after the onset of symptoms. The median CD4 cell count for the 4 patients sampled during the first month of infection was 393 cells/mm 3 , and the median log 10 plasma HIV RNA load was 6.1 copies/mm 3 . For the remaining 17 patients sampled between days 45 and 280, the CD4 cell count and median log 10 plasma HIV RNA load were 455 copies/mm 3 and 4.6 copies/mm 3 , respectively. Host cell range and NSI/SI phenotype. We found that, during the acute symptomatic stage of HIV-1 infection and throughout the first year of infection, a median of 90% of productively infected cells were CD3 T cells (range, 70%-98%; figure 1 and table 1) . Because of limitations in the quantity of tissue available for ISH and IHC, we could only evaluate the frequency of CD68 productively infected macrophages (CD68) in 10 of 21 patients. A median of 7% (range, 2%-19%) of the HIV-1 productively infected cells were identified as CD68 in sections that adjoined those in which we determined the percentage of productively infected T cells. Although the data set is incomplete, the fact that the sum of vRNA-positive T cells and macrophages approximates 100% supports the conclusion that these 2 cell types account for most, if not all, productive infections in LT.
All plasma virus isolates from the UW and UCHSC cohort and LT isolates from the UW cohort have been typed as NSI or SI in MT-2 cell cultures [11, 27] isolates had a median of 88% CD4 infected cells, compared with 90% in the 2 patients with SI virus. Although primary R5 strains are dual tropic in vitro in the cells that they infect, the proportion in vivo of vRNA-positive CD4 T cells and the predominance of productive infection in this population in early HIV-1 infection could not have been predicted. We also found that NSI/SI phenotype and SI evolution does not track changes in host cell tropisms for productive infection.
Virus production by T cells in early HIV-1 infection.
In the asymptomatic and late stages of HIV-1 infection, we previously showed that total virus production, including virus in peripheral circulation, is continuously generated in LTs, largely by activated CD4 T cells [20, 25, 28] . We sought evidence that infected T cells in LTs are responsible for virus production in early HIV-1 infection, by measuring the frequency of vRNA-positive cells. Consistent with the high virus loads in early HIV-1 infection, we found that the frequency of productively infected cells was higher shortly after HIV-1 seroconversion (figure 2) and that the frequency of vRNA-positive cells was correlated with plasma vRNA levels (figure 3). The median log 10 frequency of productively infected cells per gram of LT in the first 45 days after the onset of seroconversion symptoms was 6.45 (range, 6.35-6.56); this declined significantly to 5.54 (range, 4.49-6.14) during days 45-280 ( figure 2; ; ). The association r p .43 P p .05 between log 10 RNA and log 10 frequency of productive infection was even stronger when we considered only patients examined in the first 6 months of infection ( ; ). We also r p .55 P p .04 determined the overall log 10 frequency of vRNA-positive cells in the first 280 days of infection (median, 5.80 cells/g of LT; range, 4.49-6.56 cells/g of LT), which was not significantly different from either the presymptomatic or the symptomatic phases of the disease (5.3 and 5.5 cells/g of LT, respectively) [25, 28] . The average number of copies of vRNA per cell was not significantly different between the first 15 days of infection and days (table 2) or between averages in the presymptomatic and the later stages of infection. Accordingly, the plasma virus levels would be expected to simply reflect the number of productively infected T cells in the LT, which proved to be the case.
Evaluation of the effect of productive infection on CD4 T cell population size in LT. We used QIA of sections by IHC stained with antibodies to CD4, to determine whether the productive infection of T cells in acute and early HIV-1 infection documented in this report would be consistent with a decrease in the overall CD4 T cell population predicted by the peripheral CD4 cell count (table 3) . We previously established a pool size of CD4 T cells in a cross-sectional analysis of 6 11 ∼ 2.2 ϫ 10 HIV-1-seronegative adults [29] . Among 10 of the HIV-1-infected patients from whom tissue had been suitably preserved for this analysis, the decrease in the population in the first year of infection, compared with HIV-1-seronegative adults, was not statistically significant, despite a 10%-90% decrease in peripheral measures of CD4 cell counts, compared with an average CD4 cell count of 1000 cells/mm 3 in HIV-1-seronegative adults.
Discussion
This examination of LTs revealed aspects of HIV pathogenesis that would not have been anticipated from previous in vitro characterizations of virus strains during acute and early stages of HIV-1 infection [11, 27, 30] . We found that most vRNApositive cells are T cells in LTs from the time that persons presented with symptoms of the acute retroviral syndrome. This is in agreement with studies of acute infection in the nonhuman primate model [20, 21] and with our previous observations in presymptomatic and late stages of disease [25, 28] . Thus, HIV- 1 infection appears to be a disease primarily of T cells throughout the entire course of infection. In our report of transmission and propagation of SIV [20] , we presented data from 4 persons in the acute stages of HIV infection. Data from those persons are also included in this report, since we have extended the data set on those 4 to include not only the cellular tropisms but also the frequency of productively infected cells and copies of HIV RNA/cell. We found that the initial frequency of vRNA-positive T cells was high and then declined during the first weeks of infection, to levels typical of the chronic presymptomatic stage of infection (table 2 and figure 2). As we previously have showed in both the presymptomatic and the symptomatic late stage of disease [25, 28] , virus production and plasma virus load can be accounted for entirely by the productive infection of cells in LT. The significant correlation between virus load and frequency of productively infected T cells documented here agrees with other reports [31] and provides evidence that infected T cells in LT are also primarily responsible for virus production in the acute and early stages of HIV-1. The pattern we describe of an initial high frequency of productively infected cells and subsequent decline throughout the first year of infection differs from studies by Pantaleo et al. [32] , who found no significant differences in frequency within 3 months of the acute retroviral syndrome, compared with those in persons sampled 4-20 months after the initiation of infection. Although the basis for the discrepancy is not entirely clear, in our studies we obtained biopsy samples that were nearer to the presentation of the acute retroviral syndrome, which is characterized by very high titers of replicating virus and relatively immature immune response, a setting in which a very high frequency of productively infected cells might be expected. The greater dynamic range of frequencies of vRNA-positive cells (table 2) may have revealed the continuing decline of infected cells from the earliest stage of infection to the relatively stable levels in the presymptomatic stage.
The mechanisms that underlie changes in the frequency of vRNA-positive T cells and the relationship between productive infection and CD4 T cell depletion are probably complex. The simplest interpretation of the initial decline in the frequency of vRNA-positive cells is the emergence of virus-specific cytotoxic T lymphocytes (CTLs) that reduce the basic reproductive rate [33] but, for reasons still enigmatic, are unsuccessful in fully containing the continued propagation of virus. This interpretation is supported by many lines of evidence: temporal association of the cellular immune response with initial control of viremia [34] [35] [36] , inverse correlation between HIV-1-specific CTLs and plasma virus load [37] , and rebound in virus load in animal models when CD8 T cells are depleted [38, 39] . There is also evidence from CTL escape mutants of selective pressure exerted by CTLs [40] [41] [42] . However, virus-specific CTLs cannot be the sole explanation for the initial and continued decline in the frequency of vRNA-positive cells in this first year of infection. In addition to the observation that in many of our patients the frequency of vRNA-positive cells declined independent of CTLs [36] , critical virus-specific CD4 T cell help is lost after the early stages of infection [43, 44] . Under these conditions, it is difficult to see why there might be more CTLs or CTLs that are more effective in suppressing a progressive infection. It is more likely, in our view, that the maturing humoral immune response reduces the spread of virus locally and systemically and, in this way, reduces the overall frequency of virus-infected cells [45, 46] . We evaluated the size of the CD4 T cell population in LT, in which most of this population resides and in which most HIV-1 replication occurs, to determine whether CD4 cell depletion in LT parallels that in peripheral blood. Although the peripheral count decreased by 150% of normal values, the reduction from in HIV-1-seronegative adults to 11 2.2 ϫ 10 in primary and early HIV-1 infection is only ∼15%, 11 1.9 ϫ 10 which is in good agreement with an analysis of CD4 T cell populations in early HIV-1 infection by Fleury et al. [47] . There was no simple relationship between this reduction and the greater decrease that would have occurred from the elimination of ∼25% of the population in which HIV-1 was replicating, calculated from the daily turnover of a median log 10 5.8 cells/ g of g of LT in a 70-kg adult for a median of 133 LT ϫ 700 days. We think that this discrepancy is due to the limitations of extrapolating from a cross-sectional analysis. As we have argued elsewhere [29, 48] , more accurate prediction of the effect of HIV-1 infection on LT populations of CD4 T cells and numbers of infected cells will require further study of measures of proliferation, programmed cell death and removal, and altered trafficking [20] . Despite these limitations, the studies described here establish for the first time that HIV-1 infection is propagated for the most part in T cells by the time an infected person becomes symptomatic and that productive infection of T cells in LT is a source of virus in peripheral circulation. That LT populations of T cells are decreased by only ∼15% during the first year of infection, despite a decrease in plasma levels of 150%, is consistent with altered trafficking mechanisms that probably account for the similar disparities in later stages of infection [49, 50] . Prospective dynamic studies of LT sampled longitudinally before and after therapy has begun will be required, to gain further insight into the mechanisms of CD4 T cell depletion and repopulation in early HIV-1 infection.
